161 related articles for article (PubMed ID: 29601471)
1. Nanopulse Stimulation (NPS) Induces Tumor Ablation and Immunity in Orthotopic 4T1 Mouse Breast Cancer: A Review.
Beebe SJ; Lassiter BP; Guo S
Cancers (Basel); 2018 Mar; 10(4):. PubMed ID: 29601471
[TBL] [Abstract][Full Text] [Related]
2. Nano-pulse stimulation induces potent immune responses, eradicating local breast cancer while reducing distant metastases.
Guo S; Jing Y; Burcus NI; Lassiter BP; Tanaz R; Heller R; Beebe SJ
Int J Cancer; 2018 Feb; 142(3):629-640. PubMed ID: 28944452
[TBL] [Abstract][Full Text] [Related]
3. Nano-Pulse Stimulation Ablates Orthotopic Rat Hepatocellular Carcinoma and Induces Innate and Adaptive Memory Immune Mechanisms that Prevent Recurrence.
Lassiter BP; Guo S; Beebe SJ
Cancers (Basel); 2018 Mar; 10(3):. PubMed ID: 29533981
[TBL] [Abstract][Full Text] [Related]
4. Nano-Pulse Stimulation for the Treatment of Pancreatic Cancer and the Changes in Immune Profile.
Guo S; Burcus NI; Hornef J; Jing Y; Jiang C; Heller R; Beebe SJ
Cancers (Basel); 2018 Jun; 10(7):. PubMed ID: 29954062
[TBL] [Abstract][Full Text] [Related]
5. Nano-Pulse Stimulation is a physical modality that can trigger immunogenic tumor cell death.
Nuccitelli R; McDaniel A; Anand S; Cha J; Mallon Z; Berridge JC; Uecker D
J Immunother Cancer; 2017; 5():32. PubMed ID: 28428881
[TBL] [Abstract][Full Text] [Related]
6. Enhanced stimulation of anti-breast cancer T cells responses by dendritic cells loaded with poly lactic-co-glycolic acid (PLGA) nanoparticle encapsulated tumor antigens.
Iranpour S; Nejati V; Delirezh N; Biparva P; Shirian S
J Exp Clin Cancer Res; 2016 Oct; 35(1):168. PubMed ID: 27782834
[TBL] [Abstract][Full Text] [Related]
7. The role of reactive oxygen species in the immunity induced by nano-pulse stimulation.
Guo S; Burcus NI; Scott M; Jing Y; Semenov I
Sci Rep; 2021 Dec; 11(1):23745. PubMed ID: 34887493
[TBL] [Abstract][Full Text] [Related]
8. Nano-Pulse Stimulation induces immunogenic cell death in human papillomavirus-transformed tumors and initiates an adaptive immune response.
Skeate JG; Da Silva DM; Chavez-Juan E; Anand S; Nuccitelli R; Kast WM
PLoS One; 2018; 13(1):e0191311. PubMed ID: 29324830
[TBL] [Abstract][Full Text] [Related]
9. Photothermal-Chemotherapy Integrated Nanoparticles with Tumor Microenvironment Response Enhanced the Induction of Immunogenic Cell Death for Colorectal Cancer Efficient Treatment.
Wen Y; Chen X; Zhu X; Gong Y; Yuan G; Qin X; Liu J
ACS Appl Mater Interfaces; 2019 Nov; 11(46):43393-43408. PubMed ID: 31701733
[TBL] [Abstract][Full Text] [Related]
10. Mitochondria-Targeting Immunogenic Cell Death Inducer Improves the Adoptive T-Cell Therapy Against Solid Tumor.
Jiang Q; Zhang C; Wang H; Peng T; Zhang L; Wang Y; Han W; Shi C
Front Oncol; 2019; 9():1196. PubMed ID: 31781498
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
da Cunha A; Antoniazi Michelin M; Cândido Murta EF
Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
[TBL] [Abstract][Full Text] [Related]
12. Natural Killer T-cell Immunotherapy in Combination with Chemotherapy-Induced Immunogenic Cell Death Targets Metastatic Breast Cancer.
Gebremeskel S; Lobert L; Tanner K; Walker B; Oliphant T; Clarke LE; Dellaire G; Johnston B
Cancer Immunol Res; 2017 Dec; 5(12):1086-1097. PubMed ID: 29054890
[TBL] [Abstract][Full Text] [Related]
13. Nanosecond Pulsed Electric Fields Induce Endoplasmic Reticulum Stress Accompanied by Immunogenic Cell Death in Murine Models of Lymphoma and Colorectal Cancer.
Rossi A; Pakhomova ON; Mollica PA; Casciola M; Mangalanathan U; Pakhomov AG; Muratori C
Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31861079
[TBL] [Abstract][Full Text] [Related]
14. High hydrostatic pressure induces immunogenic cell death in human tumor cells.
Fucikova J; Moserova I; Truxova I; Hermanova I; Vancurova I; Partlova S; Fialova A; Sojka L; Cartron PF; Houska M; Rob L; Bartunkova J; Spisek R
Int J Cancer; 2014 Sep; 135(5):1165-77. PubMed ID: 24500981
[TBL] [Abstract][Full Text] [Related]
15. Tumor cell lysates as immunogenic sources for cancer vaccine design.
González FE; Gleisner A; Falcón-Beas F; Osorio F; López MN; Salazar-Onfray F
Hum Vaccin Immunother; 2014; 10(11):3261-9. PubMed ID: 25625929
[TBL] [Abstract][Full Text] [Related]
16. A protective effect after clearance of orthotopic rat hepatocellular carcinoma by nanosecond pulsed electric fields.
Chen R; Sain NM; Harlow KT; Chen YJ; Shires PK; Heller R; Beebe SJ
Eur J Cancer; 2014 Oct; 50(15):2705-13. PubMed ID: 25081978
[TBL] [Abstract][Full Text] [Related]
17. Human tumor cells killed by anthracyclines induce a tumor-specific immune response.
Fucikova J; Kralikova P; Fialova A; Brtnicky T; Rob L; Bartunkova J; Spísek R
Cancer Res; 2011 Jul; 71(14):4821-33. PubMed ID: 21602432
[TBL] [Abstract][Full Text] [Related]
18. Rapamycin Promotes Mouse 4T1 Tumor Metastasis that Can Be Reversed by a Dendritic Cell-Based Vaccine.
Lin TJ; Liang WM; Hsiao PW; M S P; Wei WC; Lin HT; Yin SY; Yang NS
PLoS One; 2015; 10(10):e0138335. PubMed ID: 26426423
[TBL] [Abstract][Full Text] [Related]
19.
Quan X; Kwak BS; Lee JY; Park JH; Lee A; Kim TH; Park S
Evid Based Complement Alternat Med; 2020; 2020():9053274. PubMed ID: 32963576
[No Abstract] [Full Text] [Related]
20. Effective cancer immunotherapy by natural mouse conventional type-1 dendritic cells bearing dead tumor antigen.
Wculek SK; Amores-Iniesta J; Conde-Garrosa R; Khouili SC; Melero I; Sancho D
J Immunother Cancer; 2019 Apr; 7(1):100. PubMed ID: 30961656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]